When Americans cast their ballots on or before Nov. 6, there’s a lot at stake for the diabetes community.
We’re not only talking healthcare and how that might be impacted by who’s chosen to be in the White House. (Sure, that’s the biggie and what most eyes are on). But it’s important not to lose sight of all the Congressional elections happening throughout the country. Hundreds of elections are slated between the Senate and House…
A rose is a rose is a rose. And so is a magnolia… even the Steel Magnolias.
The 2012 remake of the movie Steel Magnolias that hit the silver screen 23 years ago aired worldwide on Sunday evening on Lifetime TV.
Like before, the film tells the story of a young woman from the South, Shelby, who is living with type 1 diabetes and dealing with the joys and stresses of being a newlywed. It’s basically a film…
Standing in the corner of a dark room, my eyes took a few moments to adjust to the darkness.
Ten feet in front of me, my mom sat at an eye-testing device the size of an oven. Next to her, a doctor stared at a dimmed screen, with two boxes displayed — one had a close-up of my mom’s right eye showing the inside crosshairs and the other resembled a line graph of what an eye-based…
People with diabetes are living longer and healthier lives than ever. The life expectancy for PWDs has dramatically increased through the years (yay!), but that doesn’t mean that diabetes gets any easier. In fact, as the well-respected endocrinologist and person with diabetes (PWD) himself Dr. Irl Hirsch put it at a conference earlier this year: we’re seeing more “geriatric PWDs” these days and that presents a new host of issues that endocrinologists and patients traditionally…
Read more »
Three extra lines on an eye chart.
That may not seem like much at first glance (!), but those lines represent a significant step forward in the treatment of a form of diabetic retinopathy known as diabetic macular edema (DME).
In groundbreaking news this week, the Food and Drug Administration cleared the first drug of its kind to treat DME for people with diabetes, called Lucentis from California-based Genentech.
The FDA noted that this drug…